Lantheus (LNTH) Form 4: Head of R&D granted RSUs and 25,324‑share option
Rhea-AI Filing Summary
Ludger Dinkelborg, Head of Research and Development at Lantheus Holdings, Inc. (LNTH), reported equity awards dated 08/15/2025. The filing shows acquisition of 14,765 restricted stock units (RSUs) that vest in equal installments over a three-year period and a stock option covering 25,324 shares with an exercise price of $54.18. The option vests in three equal annual installments beginning 08/15/2026 and expires 08/15/2035. Following the reported transactions the reporting person beneficially owned 14,765 shares of common stock and had 25,324 option shares outstanding. The form was signed by an attorney-in-fact on 08/19/2025.
Positive
- Officer received time‑based equity awards (14,765 RSUs and a 25,324‑share option) which align management incentives with shareholders
- Clear vesting schedules disclosed: RSUs vest over three years; option vests in three equal annual installments starting 08/15/2026
Negative
- None.
Insights
TL;DR: Insider granted equity awards increase management's stake but are standard time-based compensation.
The reported awards consist of 14,765 RSUs and a 25,324-share option at a $54.18 exercise price. Time-based vesting over three years for RSUs and annual vesting starting in 2026 for the option indicate retention-focused compensation rather than immediate liquidity events. These grants are dilutive in principle but appear structured to align executive incentives with long-term share performance. No cash proceeds were reported from the RSUs; the option shows standard long-term expiry to 2035.
TL;DR: Governance signal: officer-director received routine equity awards with multi-year vesting to promote retention.
The filing identifies the reporting person as both an officer and a director and discloses detailed vesting schedules: RSUs vest evenly over three years and the option vests in three equal annual installments beginning 08/15/2026. These features are consistent with best practices for aligning executive and shareholder interests through time-based incentives. The form is properly executed by an attorney-in-fact, meeting procedural requirements for Section 16 reporting.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 25,324 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 14,765 | $0.00 | $0.00 |
Footnotes (2)
- F1. Consists of 14,765 restricted stock units that vest in equal installments over a three-year period.
- F2. The option vests in three equal annual installments beginning on August 15, 2026.
FAQ
What equity did Ludger Dinkelborg receive according to the LNTH Form 4?
When do the RSUs and options vest for the LNTH reporting person?
What is the option expiration date reported on the LNTH Form 4?
What role does the reporting person hold at Lantheus (LNTH)?
AI-generated analysis. How Rhea-AI works. Not financial advice.